Latest News
Metabolomic Characterization of Ovarian Epithelial Carcinomas by HRMAS-NMR Spectroscopy
News Sep 01, 2011Metabolomic analysis of intact tissues by HRMAS-NMR spectroscopy was shown to be a promising technique that might be applicable to the therapeutic management of patients.
READ MORE
NIH-funded Researchers Discover Genetic Link to Mesothelioma
News Aug 31, 2011Identified gene mutation may underlie other cancer types.
READ MORE
Algeta Signs License with Affibody for Tumor-Targeting Molecules
News Aug 30, 2011Algeta gains access to two proprietary Affibody® molecules for use in cancer therapy.
READ MORE
UT Southwestern Research Reveals How Cancer-Driving Enzyme Works
News Aug 30, 2011Cancer researchers unlock the cellular-level function of the telomerase enzyme, which is linked to the disease’s growth.
READ MORE
Clavis Pharma Second Quarter and First Half Report 2011
News Aug 26, 2011Clavis Pharma and Clovis Oncology expanded the LEAP study, evaluating CP-4126 vs. gemcitabine in pancreatic cancer patients.
READ MORE
FDA Grants Fast Track Designation to Alpharadin
News Aug 26, 2011Fast Track designation granted to Alpharadin for the treatment of castration-resistant prostate cancer in patients with bone metastases.
READ MORE
NIH-Funded Study Shows 20 Percent Reduction In Lung Cancer Mortality with Low-Dose CT Compared to Chest X-Ray
News Aug 24, 2011Results from the National Lung Screening Trial were published online in the New England Journal of Medicine.
READ MORE
Gladstone Scientists Offer New Insight into the Regulation of Stem Cells and Cancer Cells
News Aug 23, 2011Breakthrough discovery is likely to advance medicine and human health.
READ MORE
Immunogene Therapy Combined with Standard Treatment is Safe for Patients with Brain Tumors
News Aug 23, 2011The findings suggest that the therapy might also stimulate an immune response against the tumor.
READ MORE
Key European Patent Granted for MolMed's TK Cell Therapy
News Aug 19, 2011MolMed's investigational cell therapy product currently in Phase III for the treatment of high-risk leukaemia.
READ MORE
